Save time and get answers to complex questions with AI chat
When is xarelto's patent set to expire roughly?Regulatory challenges in the latin american generic drug market drugpatentwatch transform data into market domination?Xiaflex market launch year?Antiox mebendazole price?Is guselkumab off patent in u s?
See the DrugPatentWatch profile for keytruda
Nice question. Do you want: - US FDA timeline only, or global approvals as well? - A concise list of major milestones, or a complete, notice-by-notice list of every indication and label expansion? Quick, key milestone to start: - September 4, 2014: FDA approves pembrolizumab (Keytruda) for unresectable or metastatic melanoma — the first PD-1 inhibitor approved in the US. If you’d like, I can put together a detailed, sourced timeline with dates and indications (by year) and include milestones like major tissue-agnostic approvals and other cancer indications. Just tell me the scope you want (US-only vs global) and how detailed.
Other Questions About Keytruda :